HomeBUSINESS
BUSINESS

Nipro Grabs Rights to TC BioPharm’s CAR-T Therapy
(Feb.9.2018)

Japan’s Nipro has acquired global rights to sell and distribute a novel immunotherapy product being developed based on Scottish biotech TC BioPharm’s proprietary CAR-T platform, ImmuniCAR, the two companies said on February 7 ...
(LOG IN FOR FULL STORY)